Evidence map›Paper›PMID 24332025›Full record

ArticleImmunity2013

A long-playing CD about the γδ TCR repertoire.

Adrian Hayday, Pierre Vantourout

Abstract readComment
PubMed Publisher
In one paragraph

Article in Immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Cancer immunotherapy by γδ T cells.Science (New York, N.Y.) · 2024
    Review
  3. γδ T cells: origin and fate, subsets, diseases and immunotherapy.Signal transduction and targeted therapy · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. The Role of γδ T Cells in Fibrotic Diseases.Rambam Maimonides medical journal · 2016
    Review
  12. Article
  13. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  14. Review
  15. Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?Molecular therapy : the journal of the American Society of Gene Therapy · 2014
    Review
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Adrian HaydayPeter Gorer Department of Immunobiology, King's College London, London SE1 9RT, UK; London Research Institute, Cancer Research UK, London WC2A 3LY, UK; Medical Research Council Centre for Transplantation Biology, London SE1 9RT, UK; Comprehensive Biomedical Research Centre of Guy's and St Thomas' Hospitals and King's College London, London SE1 9RT, UK. Electronic address: adrian.hayday@kcl.ac.uk.
Pierre VantouroutPeter Gorer Department of Immunobiology, King's College London, London SE1 9RT, UK; London Research Institute, Cancer Research UK, London WC2A 3LY, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this issue of Immunity, a study by Luoma et al. (2013) provides structural evidence for direct interactions of human Vδ1(+) T cell receptors with CD1d, capping a long trail of evidence that CD1 might be a major influence on γδ T cell biology.

Indexed as

Models, MolecularAnimalsAntigens, CD1dHumansLipidsReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesAntigens, CD1dLipidsReceptors, Antigen, T-Cell, gamma-delta

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.